Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin

被引：0
|
作者：
Kristen DeCarlo
Amisha Wallia
Raymond H. Kang
Andrew Cooper
Manisha Cherupally
Sterling A. Harris
Cassandra Aikman
David T. Liss
Ronald T. Ackermann
Matthew J. O’Brien
机构：
[1] University of Illinois at Chicago,Division of Endocrinology, Diabetes and Metabolism, Department of Medicine
[2] Northwestern University Feinberg School of Medicine,Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine
[3] Northwestern University Feinberg School of Medicine,Institute of Public Health and Medicine
[4] Northwestern University Feinberg School of Medicine,Division of General Internal Medicine and Geriatrics, Department of Medicine
来源：
BMC Geriatrics | / 22卷
关键词：
Type 2 diabetes; Older adults; Antidiabetic medications; Sulfonylureas; Insulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin
    DeCarlo, Kristen
    Wallia, Amisha
    Kang, Raymond H.
    Cooper, Andrew
    Cherupally, Manisha
    Harris, Sterling A.
    Aikman, Cassandra
    Liss, David T.
    Ackermann, Ronald T.
    O'Brien, Matthew J.
    BMC GERIATRICS, 2022, 22 (01)
  • [2] Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes
    Liss, David T.
    Cherupally, Manisha
    O'Brien, Matthew J.
    Kang, Raymond H.
    Aikman, Cassandra
    Wallia, Amisha
    Cooper, Andrew J.
    Koep, Eleena
    Parker, Emily D.
    Ackermann, Ronald T.
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (12): : 661 - 668
  • [3] Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes
    O'Brien, Matthew J.
    Karam, Susan L.
    Wallia, Amisha
    Kang, Raymond H.
    Cooper, Andrew J.
    Lancki, Nicola
    Moran, Margaret R.
    Liss, David T.
    Prospect, Theodore A.
    Ackermann, Ronald T.
    JAMA NETWORK OPEN, 2018, 1 (08)
  • [4] Durable antidiabetic effect of Glyburide/Metformin tablets as second-line therapy for type 2 diabetes
    Blonde, L
    Rosenstock, J
    Piper, BA
    Henry, D
    DIABETES, 2001, 50 : A106 - A106
  • [5] Type 2 diabetes: second-line antidiabetic therapy in early pregnancy
    Clauss, Maria
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2024, 228 (02): : 119 - 119
  • [6] Cardiovascular events with second-line antidiabetic medication
    Reactions Weekly, 2019, 1735 (1) : 8 - 8
  • [7] Correlates of second-line type 2 diabetes medication selection in the USA
    Ackermann, Ronald T.
    Wallia, Amisha
    O'Brien, Matthew J.
    Kang, Raymond
    Cooper, Andrew J.
    Moran, Margaret R.
    Liss, David T.
    BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [8] Choosing a second-line therapy after metformin in type 2 diabetes mellitus
    Carol Wilson
    Nature Reviews Endocrinology, 2012, 8 (8) : 441 - 441
  • [9] Choice of second-line antidiabetic treatment in Type 2 diabetes: influence of patient characteristics
    Zghebi, S. S.
    Steinke, D. T.
    Rutter, M. K.
    Ashcroft, D. M.
    DIABETIC MEDICINE, 2015, 32 : 205 - 205
  • [10] Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study
    Chang, Y. -C.
    Chuang, L. -M.
    Lin, J. -W.
    Chen, S. -T.
    Lai, M. -S.
    Chang, C. -H.
    DIABETIC MEDICINE, 2015, 32 (11) : 1460 - 1469
12345